surgical management of oropharyngeal cancers kerry d. olsen, m.d. professor, otolaryngology head and...

11
Surgical Management of Oropharyngeal Cancers Kerry D. Olsen, M.D. Professor, Otolaryngology Head and Neck Surgery Mayo Clinic Surgical Management of Oropharyngeal Cancers Frankfurt – January 200

Upload: godfrey-gibson

Post on 17-Dec-2015

219 views

Category:

Documents


1 download

TRANSCRIPT

Surgical Managementof

Oropharyngeal Cancers

Surgical Managementof

Oropharyngeal Cancers

Kerry D. Olsen, M.D.Professor, Otolaryngology Head

and Neck SurgeryMayo Clinic

Kerry D. Olsen, M.D.Professor, Otolaryngology Head

and Neck SurgeryMayo Clinic

Surgical Management of Oropharyngeal Cancers

Frankfurt – January 2008

Advanced Oropharyngeal Cancer

Organ preservation philosophy:

Surgical Management of Oropharyngeal Cancers

Frankfurt – January 2008

• What is the functional benefit of preserving the tonsil or half of the tongue base?

The National Cancer Data Base Report on Squamous Cell Carcinoma of the

Base of TongueHead and Neck May 2004

Largest contemporary overview of presentation cure and outcome for base of tongue SCC

16,188 cases 75% Stage 3, 4(1985-1996)

Treatment % Patients Surgery 16 2,561 Radiation 24 3,972 Surgery + Rad 27 4,354 Rad + Chemo 14 2,342

Surgical Management of Oropharyngeal Cancers

Frankfurt – January 2008

Outcome:

• Early stage 1, 2 disease5-year Disease Specific SurvivalSurgery 75%Radiation 46%Rad + Chemo 29%

• Advanced stage 3, 4 disease5-year Disease Specific SurvivalSurgery + Rad 51%Surgery 42%Rad + Chemo 26%Rad 24%

Surgical Management of Oropharyngeal Cancers

Frankfurt – January 2008

Tongue BaseSquamous Cell Carcinoma

Tongue BaseSquamous Cell Carcinoma

219 patients – advanced stage 3, 4

• All completed treatment• Disease specific survival 5 yr

Surgery 83%Surgery/RT 60%Chemo/RT 23%

Kowalski, L. M.D.

219 patients – advanced stage 3, 4

• All completed treatment• Disease specific survival 5 yr

Surgery 83%Surgery/RT 60%Chemo/RT 23%

Kowalski, L. M.D.Surgical Management of Oropharyngeal Cancers

Frankfurt – January 2008

Oropharyngeal Cancer

Prevailing opinion:• Surgery

• Difficult to approach• Extensive time commitment• Poor reimbursement• Won’t eat• Leak• Send for alternative therapy

• Reality• Good function in vast majority• Short hospitalization

Surgical Management of Oropharyngeal Cancers

Frankfurt – January 2008

Oropharyngeal CancerSurgical Management

In reality, most cases:

• Don’t exhibit bone invasion (mandible)

• Don’t involve the larynx to a significant degree

• Spare one or both hypoglossal nerves

• Don’t involve majority of the soft palate

• Don’t involve carotid artery, para-pharyngeal space/pre-vertebral fascia

• Are accessible surgicallySurgical Management of Oropharyngeal Cancers

Frankfurt – January 2008

102 Patients Tonsil CancerTransoral Excision

Mayo Clinic 1996 – 2004 84% Stage 3, 4 25% S 70% S+R 5% S+R+C 5 yr L – R – D free recurrence

92% - 97% - 91% Overall survival:

• 2 yr 92%

• 5 yr 85%

Surgical Management of Oropharyngeal Cancers

Frankfurt – January 2008

Surgical Management Oropharyngeal Cancer No functional benefit to preserve tonsil or ½ tongue

base National Cancer Data Base 2004

• S 2,561 pts R 3,972 pts S+R 4,354 pts R+C 2,342 pts• Stage 1, 2 S 75% R 40% R+C 29%• Stage 3, 4 S+R 51% S 42% R+C 26% R 24%

Five year disease specific survival Stage 3, 4 tongue base cancer – 219 patients by Kowalski

• Disease specific survival 5 yr• S 83% S+R 60% R+C 23%

Tonsil Cancer – 102 patients Mayo Clinic 84% Stage 3, 4• 5 yr L – R – D free recurrence 92% - 97% - 91%• Overall survival 2 yr 92% 5 yr 85%

Surgical Management of Oropharyngeal Cancers

Frankfurt – January 2008

Surgical Management of Oropharyngeal Cancers

Frankfurt – January 2008

Surgical Management of Oropharyngeal Cancers

Frankfurt – January 2008